At $2.5-3.1 billion (bn), pharmaceutical outsourcing market (excluding contract manufacturing services) accounts for about 75 per cent of the India’s medical process outsourcing (MPO) segment which is currently estimated at $3.3–4.2 bn, according to a just concluded ASSOCHAM-EY joint study.
“While the payer outsourcing market constitutes $700-900 million (mn) of India’s MPO market, the provider market accounts for the remaining share of about $100-200 mn,” noted the study titled ‘Medical Process Outsourcing in India,’ jointly conducted by The Associated Chambers of Commerce and Industry of India (ASSOCHAM) and global professional services organisation EY. “We believe that there has been an ample push from healthcare payers, providers and pharmaceutical companies to move non-core processes to third-party service providers, and India has been one of the leading destinations for outsourcing in this space,” said D.S. Rawat, secretary general of ASSOCHAM.
